Biz Health 11 Jan 2022
"IPASA was formed out of the need for a credible, respected association to engage with stakeholders in both the private and public sectors.
Source: Supplied. Basa Pharasi, CEO of IPASASource: Supplied. Basa Pharasi, CEO of IPASA
IPASA comprises numerous research-based pharmaceutical companies and focuses on building an environment for sustainable access to innovative healthcare to address unmet medical needs.
South Africa’s pharmaceutical industry goes beyond providing health-promoting medicines; it also makes a substantial contribution to the region by investing in local healthcare and ensuring continued access to new medicines. Additionally, it stimulates the local economy through employment, taxes, skills development and technology transfer.
Medical innovations
IPASA member companies are dedicated to exploring, developing and bringing innovative, quality medicines to the South African market. They are also constantly developing therapies to prevent a variety of conditions previously considered untreatable, including infectious diseases, various forms of cancer, and neurological disorders.
Medicines developed by innovative pharma continue to benefit millions of South Africans on a daily basis. For example, mortality rates for HIV/Aids and TB in the country have fallen by 59.2% and 55.7% between 2007 and 2017. Currently, at least 60 new medicines are in the Research and Development (R&D) pipeline to treat TB.
Today, patients are living close to normal lifespans and cancer death rates have declined by 27%. Approximately 73% of survival gains in cancer are attributable to new treatments, including medicines."
Read more:
